investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian Cancer
Daniela M Dinulescu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Daniela M Dinulescu
Brigham and Women's Hospital
Boston, United States
Related projects
Heather Elizabeth Wheeler
Pharmacogenomics of the Chemotherapeutic Agent Paclitaxel
Ovary
Xiaolu Yang
Role of p53 Family Proteins in Glucose Metabolism
Ovary
Pathology
Bernard E Weissman
The Tumor Suppressor Role of SMARCA4 in SCCOHT
Ovary
Pathology
Jeffrey Gildersleeve
Serum Antibody Profiling with a Carbohydrate Microarray
Ovary
Pathology
Katarzyna Slowinska
Rigid-rod Peptides as Nanocarriers for Delivery of Cancer Drugs
Ovary
Hans Schreiber
Manipulation of Tumor Specific Immunity
Ovary
Pathology
Sara Lindstroem
Quantifying and Characterizing the shared genetic contribution to common cancers
Ovary
Martin Mcintosh
Profiling cancer neoantigen repertoires and validating immunotherapy targets
Ovary
Michael Gottesman
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
Ovary